Tokushima Prefectural Central Hospital

Tokushima, Tokushima 770-8539

2 studies enrolling now · 3 studies all time

What they study most

Multiple Myeloma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM)

Studies at this site

• Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma — Recruiting now
• A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma — Recruiting now
• Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. — Completed